U
SciSparc Ltd. SPRC
$1.75 -$0.09-4.89% NASDAQ
Recommendation
Prev Close
$1.75
Volume
11,002
Avg Vol (90D)
3,944,731
Market Cap
$2.84M
Dividend & Yield
--
52-Week Range
$1.60 - $37.59
P/E (TTM)
0.33
EPS (TTM)
$5.29
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
SciSparc's NeuroThera Labs Eyes Quantum Leap with New Acquisition
12/2/2025 - TipRanks Financial Blog
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum ...
12/2/2025 - GuruFocus
SciSparc (SPRC) Acquires Interest in Quantum Computing Bio Data Company
12/2/2025 - GuruFocus
NeuroThera to acquire 55% stake in quantum computing bio data company
12/2/2025 - TipRanks Financial Blog
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company
12/2/2025 - Globe Newswire
SciSparc (SPRC) to Acquire Patents for Innovative Endoscopic Systems
12/1/2025 - GuruFocus
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an ...
12/1/2025 - GuruFocus
SciSparc plans to enter GERD device market with IP portfolio acquisition
12/1/2025 - The Fly
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio
12/1/2025 - Globe Newswire
Why SciSparc Stock Is Gaining Today
11/26/2025 - Benzinga
SciSparc (SPRC) to Acquire Key Patents and IP for Medical Devices
11/26/2025 - GuruFocus
SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech
11/26/2025 - Stocktwits News Feed
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems
11/26/2025 - GuruFocus
SciSparc to acquire treasury of patents for medical endoscopy systems
11/26/2025 - The Fly
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems
11/26/2025 - Globe Newswire
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
11/23/2025 - Market Exclusive
SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind ...
11/20/2025 - GuruFocus
SciSparc, Clearmind Medicine file Israeli patent application for depression
11/20/2025 - TipRanks Financial Blog
SciSparc, Clearmind Medicine file Israeli patent application for depression
11/20/2025 - The Fly
SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
11/20/2025 - Globe Newswire
SciSparc Ltd. Releases Interim Financial Results for H1 2025
11/18/2025 - TipRanks Financial Blog
Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
11/17/2025 - Globe Newswire
N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers
10/30/2025 - Globe Newswire
SciSparc (SPRC) Acquires Controlling Stake in Neurothera Labs
10/24/2025 - GuruFocus
SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which ...
10/24/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
--
Total Debt (Q)
$0.00
Total Liabilities (Q)
--
Book Value Per Share (Q)
--
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, November 20, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Apr 20 and 24 (est)
Price History
Loading...
Beta
1.40
7-Day Total Return
-27.39%
30-Day Total Return
-58.82%
60-Day Total Return
-2.78%
90-Day Total Return
-76.09%
Year to Date Total Return
-78.77%
1-Year Total Return
-61.37%
2-Year Total Return
-98.86%
3-Year Total Return
-99.71%
5-Year Total Return
--
52-week Low
Dec 02, 2025 - $1.60
52-week High
Jan 06, 2025 - $37.59
Valuation
Market Cap
$2.84M - Nano Cap
Enterprise Value
$4.11M
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
0.52
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
scisparc.com
Phone Number
972 7 334 47180
Address
Tower A
2nd Floor - 20 Raul Wallenberg Street
Tel Aviv, 6971916
Country
Israel
Year Founded
2004
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and... more
NASDAQ 12/02/2025 4:00PM Eastern Quotes delayed